在心脏衰竭中出现虚弱,萨科佩尼亚,白内障和营养不良
Daichi Maeda1, Yudai Fujimoto1, Taisuke Nakade1
1Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Korean circulation journal
|May 20, 2024
概括
心力衰竭患者往往会经历虚弱,肉,缓冲症和营养不良. 早期识别和综合管理策略对于改善这一老龄化人口的结果至关重要.
科学领域:
- 老年病学和心脏病学.
- 临床医学 临床医学
背景情况:
- 全球老龄化增加了心力衰竭的患病率.
- 心力衰竭与虚弱,肉,缓解衰竭和营养不良有关,影响预后.
- 这些情况往往并存,并在心力衰竭患者中共享重叠的诊断标准.
研究的目的:
- 审查心力衰竭中的虚弱性,肉症,缓解衰竭和营养不良的流行病学,诊断,重叠和预后.
- 讨论这些条件对指导方针导向医疗疗疗法的有效性的影响.
- 将来自FRAGILE-HF研究的见解纳入其中.
主要方法:
- 文献审查和现有数据的分析.
- 检查诊断标准和流行病学趋势.
- 综合与心力衰竭并发症相关的发现.
主要成果:
- 虚弱,肉,缓冲症和营养不良非常普遍,并且在心力衰竭中相互关联.
- 这些情况可能会影响标准心力衰竭治疗的疗效.
- FRAGILE-HF研究为这些复杂的关系提供了关键的见解.
结论:
- 对心力衰竭患者来说,对这些并发症的全面了解和管理至关重要.
- 早期识别和综合干预可以改善患者的治疗结果.
- 需要进一步的大规模随机对照试验来优化个性化治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570
The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Pathophysiology of Cardiac Performance
638
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
638


